Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.
Identifieur interne : 001452 ( PubMed/Curation ); précédent : 001451; suivant : 001453Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.
Auteurs : Ram Kumar Adhikari [Oman] ; Jeevan Bahadur Sherchand ; Shiva Raj Mishra ; Kamal Ranabhat ; Rajendra Raj WagleSource :
- Journal of community health [ 1573-3610 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Agents de santé communautaire, Connaissances, attitudes et pratiques en santé, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (effets indésirables), Diéthylcarbamazine (usage thérapeutique), Facteurs socioéconomiques, Femelle, Filaricides (administration et posologie), Filaricides (effets indésirables), Filaricides (usage thérapeutique), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (épidémiologie), Humains, Mâle, Népal (épidémiologie), Observance du traitement médicamenteux (), Observance du traitement médicamenteux (psychologie), Éducation du patient comme sujet (organisation et administration), Études transversales.
- MESH :
- administration et posologie : Diéthylcarbamazine, Filaricides.
- effets indésirables : Diéthylcarbamazine, Filaricides.
- organisation et administration : Éducation du patient comme sujet.
- psychologie : Observance du traitement médicamenteux.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Diéthylcarbamazine, Filaricides.
- épidémiologie : Filariose lymphatique, Népal.
- Adulte, Adulte d'âge moyen, Agents de santé communautaire, Connaissances, attitudes et pratiques en santé, Facteurs socioéconomiques, Femelle, Humains, Mâle, Observance du traitement médicamenteux, Études transversales.
- Wicri :
- geographic : Népal.
English descriptors
- KwdEn :
- Adult, Community Health Workers, Cross-Sectional Studies, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (adverse effects), Diethylcarbamazine (therapeutic use), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (epidemiology), Female, Filaricides (administration & dosage), Filaricides (adverse effects), Filaricides (therapeutic use), Health Knowledge, Attitudes, Practice, Humans, Male, Medication Adherence (psychology), Medication Adherence (statistics & numerical data), Middle Aged, Nepal (epidemiology), Patient Education as Topic (organization & administration), Socioeconomic Factors.
- MESH :
- chemical , administration & dosage : Diethylcarbamazine, Filaricides.
- chemical , adverse effects : Diethylcarbamazine, Filaricides.
- chemical , therapeutic use : Diethylcarbamazine, Filaricides.
- geographic , epidemiology : Nepal.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- organization & administration : Patient Education as Topic.
- psychology : Medication Adherence.
- statistics & numerical data : Medication Adherence.
- Adult, Community Health Workers, Cross-Sectional Studies, Female, Health Knowledge, Attitudes, Practice, Humans, Male, Middle Aged, Socioeconomic Factors.
Abstract
Lymphatic filariasis (LF) is among the major public health problems in Nepal. The disease is a major cause of morbidities primarily, lymphedema of legs and hydrocele and it impedes socio economic development in many endemic areas of the country. This study is aimed at exploring the understanding of people about mass drug administration (MDA) of the said disease and the status of compliance of MDA in Nepal. This study is a cross sectional study carried out among 894 household samples in three of the sixty LF endemic districts. The selected districts were Dhading, Kapilvastu and Kailali. The sentinel surveillance of sites in three districts constituted the sampling frame at the first stage. The peripheral health care centers in the sentinel sites constituted the sampling frame at the second stage of sampling. The coverage of MDA was 95.5 %. However, the compliance was less. Only 71.6 % of the respondents who took the drugs from health workers swallowed the diethyl carbamazine (DEC) completely, other did not swallow. In the present study, majority of respondents reported that they had heard or seen persons with side effects of DEC in their community. A total of 20 % of respondents reported that they had side effects after having DEC and only 3.9 % of these side effects were treated. The Female Community Health volunteers (FCHVs), health workers and radio/Television (TV) were the chief sources of MDA related information. This study recommends for a concerted public health action combining effective drug delivery mechanism and sound public awareness campaigns. The community people need to be made aware beforehand about the location, time of drug distribution. Also public awareness of the DEC should be conducted so that people would trust it and comply with the drug regime. Along with the health workers and radio/TV that has been used traditionally, we recommend mobilization of FCHVs in the public awareness campaigns the MDA campaigns.
DOI: 10.1007/s10900-014-9891-1
PubMed: 24996654
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001452
Links to Exploration step
pubmed:24996654Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.</title><author><name sortKey="Adhikari, Ram Kumar" sort="Adhikari, Ram Kumar" uniqKey="Adhikari R" first="Ram Kumar" last="Adhikari">Ram Kumar Adhikari</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Maharajgunj Medical Campus, P.O.BOX 1524, Kathmandu, Nepal, drradhikari@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Institute of Medicine, Maharajgunj Medical Campus, P.O.BOX 1524, Kathmandu, Nepal</wicri:regionArea></affiliation></author><author><name sortKey="Sherchand, Jeevan Bahadur" sort="Sherchand, Jeevan Bahadur" uniqKey="Sherchand J" first="Jeevan Bahadur" last="Sherchand">Jeevan Bahadur Sherchand</name></author><author><name sortKey="Mishra, Shiva Raj" sort="Mishra, Shiva Raj" uniqKey="Mishra S" first="Shiva Raj" last="Mishra">Shiva Raj Mishra</name></author><author><name sortKey="Ranabhat, Kamal" sort="Ranabhat, Kamal" uniqKey="Ranabhat K" first="Kamal" last="Ranabhat">Kamal Ranabhat</name></author><author><name sortKey="Wagle, Rajendra Raj" sort="Wagle, Rajendra Raj" uniqKey="Wagle R" first="Rajendra Raj" last="Wagle">Rajendra Raj Wagle</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:24996654</idno><idno type="pmid">24996654</idno><idno type="doi">10.1007/s10900-014-9891-1</idno><idno type="wicri:Area/PubMed/Corpus">001452</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001452</idno><idno type="wicri:Area/PubMed/Curation">001452</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001452</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.</title><author><name sortKey="Adhikari, Ram Kumar" sort="Adhikari, Ram Kumar" uniqKey="Adhikari R" first="Ram Kumar" last="Adhikari">Ram Kumar Adhikari</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Medicine, Maharajgunj Medical Campus, P.O.BOX 1524, Kathmandu, Nepal, drradhikari@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Institute of Medicine, Maharajgunj Medical Campus, P.O.BOX 1524, Kathmandu, Nepal</wicri:regionArea></affiliation></author><author><name sortKey="Sherchand, Jeevan Bahadur" sort="Sherchand, Jeevan Bahadur" uniqKey="Sherchand J" first="Jeevan Bahadur" last="Sherchand">Jeevan Bahadur Sherchand</name></author><author><name sortKey="Mishra, Shiva Raj" sort="Mishra, Shiva Raj" uniqKey="Mishra S" first="Shiva Raj" last="Mishra">Shiva Raj Mishra</name></author><author><name sortKey="Ranabhat, Kamal" sort="Ranabhat, Kamal" uniqKey="Ranabhat K" first="Kamal" last="Ranabhat">Kamal Ranabhat</name></author><author><name sortKey="Wagle, Rajendra Raj" sort="Wagle, Rajendra Raj" uniqKey="Wagle R" first="Rajendra Raj" last="Wagle">Rajendra Raj Wagle</name></author></analytic><series><title level="j">Journal of community health</title><idno type="eISSN">1573-3610</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Community Health Workers</term><term>Cross-Sectional Studies</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (adverse effects)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Female</term><term>Filaricides (administration & dosage)</term><term>Filaricides (adverse effects)</term><term>Filaricides (therapeutic use)</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Male</term><term>Medication Adherence (psychology)</term><term>Medication Adherence (statistics & numerical data)</term><term>Middle Aged</term><term>Nepal (epidemiology)</term><term>Patient Education as Topic (organization & administration)</term><term>Socioeconomic Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Agents de santé communautaire</term><term>Connaissances, attitudes et pratiques en santé</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Diéthylcarbamazine (effets indésirables)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Filaricides (administration et posologie)</term><term>Filaricides (effets indésirables)</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Mâle</term><term>Népal (épidémiologie)</term><term>Observance du traitement médicamenteux ()</term><term>Observance du traitement médicamenteux (psychologie)</term><term>Éducation du patient comme sujet (organisation et administration)</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Nepal</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Éducation du patient comme sujet</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Patient Education as Topic</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Observance du traitement médicamenteux</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Medication Adherence</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Medication Adherence</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Népal</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Community Health Workers</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Socioeconomic Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Agents de santé communautaire</term><term>Connaissances, attitudes et pratiques en santé</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Observance du traitement médicamenteux</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Népal</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphatic filariasis (LF) is among the major public health problems in Nepal. The disease is a major cause of morbidities primarily, lymphedema of legs and hydrocele and it impedes socio economic development in many endemic areas of the country. This study is aimed at exploring the understanding of people about mass drug administration (MDA) of the said disease and the status of compliance of MDA in Nepal. This study is a cross sectional study carried out among 894 household samples in three of the sixty LF endemic districts. The selected districts were Dhading, Kapilvastu and Kailali. The sentinel surveillance of sites in three districts constituted the sampling frame at the first stage. The peripheral health care centers in the sentinel sites constituted the sampling frame at the second stage of sampling. The coverage of MDA was 95.5 %. However, the compliance was less. Only 71.6 % of the respondents who took the drugs from health workers swallowed the diethyl carbamazine (DEC) completely, other did not swallow. In the present study, majority of respondents reported that they had heard or seen persons with side effects of DEC in their community. A total of 20 % of respondents reported that they had side effects after having DEC and only 3.9 % of these side effects were treated. The Female Community Health volunteers (FCHVs), health workers and radio/Television (TV) were the chief sources of MDA related information. This study recommends for a concerted public health action combining effective drug delivery mechanism and sound public awareness campaigns. The community people need to be made aware beforehand about the location, time of drug distribution. Also public awareness of the DEC should be conducted so that people would trust it and comply with the drug regime. Along with the health workers and radio/TV that has been used traditionally, we recommend mobilization of FCHVs in the public awareness campaigns the MDA campaigns.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24996654</PMID><DateCreated><Year>2015</Year><Month>01</Month><Day>20</Day></DateCreated><DateCompleted><Year>2015</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2015</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-3610</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of community health</Title><ISOAbbreviation>J Community Health</ISOAbbreviation></Journal><ArticleTitle>Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.</ArticleTitle><Pagination><MedlinePgn>34-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10900-014-9891-1</ELocationID><Abstract><AbstractText>Lymphatic filariasis (LF) is among the major public health problems in Nepal. The disease is a major cause of morbidities primarily, lymphedema of legs and hydrocele and it impedes socio economic development in many endemic areas of the country. This study is aimed at exploring the understanding of people about mass drug administration (MDA) of the said disease and the status of compliance of MDA in Nepal. This study is a cross sectional study carried out among 894 household samples in three of the sixty LF endemic districts. The selected districts were Dhading, Kapilvastu and Kailali. The sentinel surveillance of sites in three districts constituted the sampling frame at the first stage. The peripheral health care centers in the sentinel sites constituted the sampling frame at the second stage of sampling. The coverage of MDA was 95.5 %. However, the compliance was less. Only 71.6 % of the respondents who took the drugs from health workers swallowed the diethyl carbamazine (DEC) completely, other did not swallow. In the present study, majority of respondents reported that they had heard or seen persons with side effects of DEC in their community. A total of 20 % of respondents reported that they had side effects after having DEC and only 3.9 % of these side effects were treated. The Female Community Health volunteers (FCHVs), health workers and radio/Television (TV) were the chief sources of MDA related information. This study recommends for a concerted public health action combining effective drug delivery mechanism and sound public awareness campaigns. The community people need to be made aware beforehand about the location, time of drug distribution. Also public awareness of the DEC should be conducted so that people would trust it and comply with the drug regime. Along with the health workers and radio/TV that has been used traditionally, we recommend mobilization of FCHVs in the public awareness campaigns the MDA campaigns.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adhikari</LastName><ForeName>Ram Kumar</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Maharajgunj Medical Campus, P.O.BOX 1524, Kathmandu, Nepal, drradhikari@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherchand</LastName><ForeName>Jeevan Bahadur</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Shiva Raj</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Ranabhat</LastName><ForeName>Kamal</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Wagle</LastName><ForeName>Rajendra Raj</ForeName><Initials>RR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Community Health</MedlineTA><NlmUniqueID>7600747</NlmUniqueID><ISSNLinking>0094-5145</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003150" MajorTopicYN="N">Community Health Workers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009390" MajorTopicYN="N" Type="Geographic">Nepal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010353" MajorTopicYN="N">Patient Education as Topic</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24996654</ArticleId><ArticleId IdType="doi">10.1007/s10900-014-9891-1</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001452 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001452 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24996654
|texte= Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24996654" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |